BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 402759)

  • 1. Effect of alpha-MSH on the tyrosinase activity and the rate of melanin accumulation of melanoma cells in vitro.
    Lee TH; Lee MS
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):663-72. PubMed ID: 402759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-MSH on melanogenesis and tyrosinase of B-16 melanoma.
    Lee TH; Lee MS; Lu MY
    Endocrinology; 1972 Nov; 91(5):1180-8. PubMed ID: 4627367
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
    Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
    Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures.
    Fuller BB; Lunsford JB; Iman DS
    J Biol Chem; 1987 Mar; 262(9):4024-33. PubMed ID: 3031058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.
    Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Bregman MD; Hruby VJ; Meyskens FL
    In Vitro Cell Dev Biol; 1986 Feb; 22(2):75-81. PubMed ID: 3081484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle.
    Abdel-Malek ZA; Swope VB; Trinkle LS; Nordlund JJ
    Exp Cell Res; 1989 Jan; 180(1):198-208. PubMed ID: 2462505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
    Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
    Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle.
    Fuller BB; Brooks BA
    Exp Cell Res; 1980 Mar; 126(1):183-90. PubMed ID: 6766870
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemistry of melanin synthesis: in vivo effects of MSH on tyrosinase and melanogenesis of pigmentary system.
    Lee TH; Lee MS
    Yale J Biol Med; 1973 Dec; 46(5):493-9. PubMed ID: 4205116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
    Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
    Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A; Moellmann G; Kuklinska E
    J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-tyrosinase inhibition of melanogenesis by melatonin in hair follicles in vitro.
    Logan A; Weatherhead B
    J Invest Dermatol; 1980 Jan; 74(1):47-50. PubMed ID: 6766170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin.
    Körner A; Pawelek J
    Science; 1982 Sep; 217(4565):1163-5. PubMed ID: 6810464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP.
    Hoganson GE; Ledwitz-Rigby F; Davidson RL; Fuller BB
    Somat Cell Mol Genet; 1989 May; 15(3):255-63. PubMed ID: 2543086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear nonhistone proteins in murine melanoma cells: II. changes following exposure to MSH.
    Wikswo MA; McGuire J; Shansky JE; Boshes RA
    J Invest Dermatol; 1977 Dec; 69(6):516-20. PubMed ID: 411835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of two melanocytolytic agents, hydroquinone and beta-mercaptoethanolamine, upon tyrosinase activity and cyclic nucleotide levels in murine melanomas.
    Abramowitz J; Chavin W
    Chem Biol Interact; 1980 Oct; 32(1-2):195-208. PubMed ID: 6253089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.
    Pawelek J; Sansone M; Koch N; Christie G; Halaban R; Hendee J; Lerner AB; Varga JM
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):951-5. PubMed ID: 165495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
    Wick MM; Frei E
    Cancer Res; 1977 Jul; 37(7 Pt 1):2123-5. PubMed ID: 861938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.